Centro Sperimentale del Latte (CSL) was the first company in Italy to study Lactic Acid Bacteria (LAB) for human health. It was founded by Dr Leo Vesely in 1948 with a mission to improve maternal health and children’s nutrition. Since 2013 CSL has been part of Sacco System, the international biotech hub, for food, nutraceutical, and pharmaceutical industries; our expertise helps solve consumer needs in more than 110 countries around the world, leveraging our unique proprietary strains and customised blends. After more than 70 years, CSL continue to focus on probiotic manufacturing, research and development for nutraceutical and pharmaceutical fields. Our know-how is not limited to LAB, but with our two facilities, drug-GMP certified we can support companies in the development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obligate aerobes and anaerobes strains) and biotherapeutics (BPs)
SACCO SYSTEM
Latest Content
6 ways to transform live biotherapeutic products into commercial success
Paid for and content provided by SACCO SYSTEM
Manufacturing LBPs at industrial scale involves equipment and processing methods that can vary from those at development and semi-industrial scale. Sacco System can support your project all the way to commercial manufacture.
Respiratory infections: CRL 1505, a probiotic that can help
Paid for and content provided by SACCO SYSTEM
Respiratory Tract Infections (RTIs) affect one’s sinuses, throat, airways, and/or lungs. RTIs are a persistent and costly public health problem that even before COVID-19 pandemic were among the primary causes of death worldwide. The COVID-19 pandemic has...